Supo-Aromasin© (25mg/tab) – Beligas

Introduction

Supo-Aromasin© (25mg/tab) is a product manufactured by Beligas Pharmaceuticals, containing the active ingredient exemestane. Exemestane is an aromatase inhibitor primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is available in a tablet form, with each tablet containing 25mg of exemestane.

Exemestane: An Overview

Exemestane belongs to a class of drugs known as aromatase inhibitors. It works by reducing the production of estrogen in the body, which is essential for the growth of hormone receptor-positive breast cancer cells. By inhibiting the aromatase enzyme, exemestane effectively reduces estrogen levels, thereby slowing down tumor growth and preventing cancer recurrence.

Exemestane 25 mg vs Anastrozole

Exemestane and anastrozole are both commonly used aromatase inhibitors in the treatment of hormone receptor-positive breast cancer. While they have similar mechanisms of action, there are some differences between the two medications:

• Efficacy: In a clinical trial comparing exemestane and anastrozole as adjuvant treatment for postmenopausal women with hormone receptor-positive early breast cancer, exemestane showed similar efficacy in preventing cancer recurrence but with fewer side effects than anastrozole (source).
• Side effects: Exemestane has been found to have a more favorable side effect profile compared to anastrozole. Common side effects of exemestane include hot flashes, fatigue, and joint pain, while anastrozole is associated with a higher incidence of musculoskeletal symptoms and vaginal dryness (source).

Supo-Aromasin©: Quality and Effectiveness

Beligas Pharmaceuticals is a reputable manufacturer known for producing high-quality pharmaceutical products. Supo-Aromasin© is no exception. The 25mg tablets of Supo-Aromasin© contain the precise dosage of exemestane required for effective treatment of hormone receptor-positive breast cancer.

Supo-Aromasin© has been extensively studied and proven to be effective in clinical trials. For example, a study evaluating the use of exemestane as adjuvant therapy in postmenopausal women with early-stage breast cancer showed a significant reduction in the risk of cancer recurrence with the use of exemestane (source).

How to Take Supo-Aromasin©

Supo-Aromasin© should be taken exactly as prescribed by a healthcare professional. The usual recommended dosage is 25mg per day, which can be taken with or without food. It is important to follow the prescribed dosage and duration of treatment to achieve optimal results.

Possible Side Effects

Like any medication, Supo-Aromasin© may cause side effects. Common side effects include:

• Hot flashes
• Fatigue
• Joint pain
• Headache
• Insomnia

If any severe or persistent side effects occur, it is important to consult a healthcare professional for further evaluation.

Conclusion

Supo-Aromasin© (25mg/tab) by Beligas Pharmaceuticals is a high-quality product containing the active ingredient exemestane. Exemestane is an effective aromatase inhibitor used in the treatment of hormone receptor-positive breast cancer. Compared to anastrozole, exemestane has shown similar efficacy with a more favorable side effect profile.

Supo-Aromasin© has been proven effective in clinical trials and is recommended for postmenopausal women with hormone receptor-positive breast cancer. As with any medication, it is important to follow the prescribed dosage and consult a healthcare professional for any concerns or side effects.